BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38743424)

  • 1. Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance.
    Wong RJ; Jones PD; Niu B; Therapondos G; Thamer M; Kshirsagar O; Zhang Y; Pinheiro P; Kyalwazi B; Fass R; Khalili M; Singal AG
    JAMA Netw Open; 2024 May; 7(5):e2411076. PubMed ID: 38743424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.
    Dalton-Fitzgerald E; Tiro J; Kandunoori P; Halm EA; Yopp A; Singal AG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):791-8.e1. PubMed ID: 25019694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
    Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
    Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.
    Simmons OL; Feng Y; Parikh ND; Singal AG
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):766-773. PubMed ID: 30056183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.
    Singal AG; Tiro JA; Murphy CC; Blackwell JM; Kramer JR; Khan A; Liu Y; Zhang S; Phillips JL; Hernaez R
    Clin Gastroenterol Hepatol; 2021 May; 19(5):987-995.e1. PubMed ID: 32629122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
    Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Rich NE; Singal AG; Aby ES; Yang JD; Nguyen V; Pillai A; Fuchs M; Moon AM; Shroff H; Agarwal PD; Perumalswami P; Chandna S; Zhou K; Patel YA; Latt NL; Wong R; Duarte-Rojo A; Lindenmeyer CC; Frenette C; Ge J; Mehta N; Yao F; Benhammou JN; Bloom PP; Leise M; Kim HS; Levy C; Barnard A; Khalili M; Ioannou GN
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):183-193. PubMed ID: 32927050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers.
    McGowan CE; Edwards TP; Luong MU; Hayashi PH
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):799-804. PubMed ID: 25117773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
    Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
    JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
    Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.
    Wolf E; Rich NE; Marrero JA; Parikh ND; Singal AG
    Hepatology; 2021 Feb; 73(2):713-725. PubMed ID: 32383272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
    Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers.
    Mahfouz M; Nguyen H; Tu J; Diaz CR; Anjan S; Brown S; Bosire K; Carrasquillo O; Martin P; Jones PD
    Dig Dis Sci; 2020 Sep; 65(9):2551-2561. PubMed ID: 31813133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Physician Self-reported Knowledge and Use of Maryland's Extreme Risk Protection Order Law.
    Frattaroli S; Hoops K; Irvin NA; McCourt A; Nestadt PS; Omaki E; Shields WC; Wilcox HC
    JAMA Netw Open; 2019 Dec; 2(12):e1918037. PubMed ID: 31860108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey.
    Teerasarntipan T; Sritunyarat Y; Prathyajuta P; Pitakkitnukun P; Phathong C; Ariyaskul D; Kulkraisri K; Tangkijvanich P; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
    Medicine (Baltimore); 2022 Sep; 101(36):e30538. PubMed ID: 36086710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic.
    Serper M; Tapper EB; Kaplan DE; Taddei TH; Mahmud N
    Am J Gastroenterol; 2023 Feb; 118(2):294-303. PubMed ID: 36114778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists.
    Sharma P; Saini SD; Kuhn LB; Rubenstein JH; Pardi DS; Marrero JA; Schoenfeld PS
    Dig Dis Sci; 2011 Feb; 56(2):569-77. PubMed ID: 20978844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.
    Davila JA; Morgan RO; Richardson PA; Du XL; McGlynn KA; El-Serag HB
    Hepatology; 2010 Jul; 52(1):132-41. PubMed ID: 20578139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for hepatocellular carcinoma at the community level: Easier said than done.
    Del Poggio P; Mazzoleni M; Lazzaroni S; D'Alessio A
    World J Gastroenterol; 2021 Oct; 27(37):6180-6190. PubMed ID: 34712026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure rates in the hepatocellular carcinoma surveillance process.
    Singal AG; Yopp AC; Gupta S; Skinner CS; Halm EA; Okolo E; Nehra M; Lee WM; Marrero JA; Tiro JA
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1124-30. PubMed ID: 22846843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.